DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
Provided By GlobeNewswire
Last update: Oct 18, 2024
Châtillon, France, October 18, 2024
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participation at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting, October 24 – 28th, 2024 in Boston, Massachusetts.
Read more at globenewswire.com
